Mallinckrodt announced that the FDA has granted Fast Track designation to the Investigational New Drug (IND) application of Synacthen Depot (tetracosactide) for the treatment of Duchenne muscular ...

Injecting performance enhancing corticosteroid hormones for other than medical treatment is banned, and tests exist that can detect injected hormones. Injecting synacthen, which stimulates the body to ...

Mallinckrodt plc MNK revealed Monday that it submitted an Investigational New Drug (IND) application for Synacthen Depot to the U.S. Food and Drug Administration (FDA). The company indicated that it ...

Why try to beat 'em if you can just buy 'em? That's the approach that Questcor Pharmaceuticals is taking. The biotech announced today that it has acquired rights to develop Syncathen and Synacthen ...

Martin Shkreli blew the whistle on a UK drugmaker, which is now being sued by the FTC. Illustration by the New York Post The Federal Trade Commission, following an exclusive report by The Post, has ...